Final Clinical Outcomes from a Phase 2 Trial of Posoleucel, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Prevention of Clinically Significant Viral Infections Post-HCT

Autor: Sanjeet S Dadwal, Jo-Anne H. Young, Michael W. Schuster, Jean A. Yared, Gary Douglas Myers, Michelle Matzko, Sama Adnan, Joshua A. Hill, Rajat Bansal
Rok vydání: 2022
Předmět:
Zdroj: Blood. 140:878-879
ISSN: 1528-0020
0006-4971
DOI: 10.1182/blood-2022-169122
Databáze: OpenAIRE